Mixed lineage leukemia (MLL) is a malignant hematological tumor with high incidence and poor prognosis and is caused by rearrangements in the allele of MLL1 (Hilden et al., 2006; Krivtsov and Armstrong, 2007). This evidence concerns the gene KMT2A and leukemia.